has knowledgeable contact person
uses tool
uses biomaterial
Protocols  >  Post-clinical protocol  >  Immune monitoring of DC vac...

Immune monitoring of DC vaccinated advanced melanoma patients

Post-clinical protocol

IFNgamma ELISPOT of peptide pulsed, leukapheresis derived PBMC
Tumor antigen specific activation of CD8 and CD4 DTH infiltrating T cells (CD137, CD107a, CD154, cytokines TNFalpha and IFNgamma)

Protocol Steps:
Immune monitoring of DC vaccinated advanced melanoma patients Graph


created over 8 years ago (2 March 2009)    last modified over 5 years ago (28 September 2011)   [ RDF Rdf ]   [ RelFinder Relfinder ]